Greenfield Seitz Capital Management’s Dr. Reddy's Laboratories RDY Stock Holding History

Greenfield Seitz Capital Management’s Portfolio RDY Stock Details RDY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$623K	Sell	43,000 -250	-0.6%	-$3.37K	0.19%	74
2026 Q1	$599K	Hold	43,250	–	–	0.18%	76
2025 Q4	$607K	Hold	43,250	–	–	0.2%	74
2025 Q3	$605K	Hold	43,250	–	–	0.19%	73
2025 Q2	$650K	Hold	43,250	–	–	0.23%	66
2025 Q1	$570K	Sell	43,250 -10,000	-19%	-$138K	0.22%	73
2024 Q4	$841K	Hold	53,250	–	–	0.32%	62
2024 Q3	$846K	Hold	53,250	–	–	0.31%	61
2024 Q2	$811K	Hold	53,250	–	–	0.3%	67
2024 Q1	$781K	Hold	53,250	–	–	0.29%	66
2023 Q4	$741K	Buy	+53,250	New	+$712K	0.3%	67

Other funds holding RDY

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

AIM

Aikya Investment Management London, United Kingdom $341M AUM 28.74% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Greenfield Seitz Capital Management's RDY Position: Q2 2026 in Review

Greenfield Seitz Capital Management reduced its Dr. Reddy's Laboratories (RDY) stake by 0.58% in Q2 2026, selling an estimated $3.37K and leaving 43,000 shares worth $623K. The position accounts for 0.19% of the portfolio, ranked #74.

Greenfield Seitz Capital Management first reported a position in RDY in Q4 2023 and has held it in 11 quarters since. The position peaked at $846K in Q3 2024. 238 funds tracked by Wall St. Rank hold RDY as of Q2 2026.

Greenfield Seitz Capital Management held 43,000 shares of Dr. Reddy's Laboratories worth $623K as of Q2 2026.
Greenfield Seitz Capital Management sold 250 Dr. Reddy's Laboratories shares in Q2 2026, an estimated $3.37K.
Dr. Reddy's Laboratories made up 0.19% of Greenfield Seitz Capital Management's portfolio in Q2 2026, its #74 holding.
Greenfield Seitz Capital Management first reported a position in Dr. Reddy's Laboratories in Q4 2023 and has held it in 11 quarters since.
Greenfield Seitz Capital Management's Dr. Reddy's Laboratories position peaked at $846K in Q3 2024.
238 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q2 2026.

Based on Greenfield Seitz Capital Management's 13F filing for Q2 2026, filed 12 Aug 2026.